287 related articles for article (PubMed ID: 10864664)
1. The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.
Mobley CM; Sealy L
J Virol; 2000 Jul; 74(14):6511-9. PubMed ID: 10864664
[TBL] [Abstract][Full Text] [Related]
2. Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity.
Mobley CM; Sealy L
J Virol; 1998 Aug; 72(8):6592-601. PubMed ID: 9658104
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein.
Yeh CH; Shatkin AJ
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11002-6. PubMed ID: 7971997
[TBL] [Abstract][Full Text] [Related]
4. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
[TBL] [Abstract][Full Text] [Related]
5. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
Bowers WJ; Baglia LA; Ruddel A
J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
[TBL] [Abstract][Full Text] [Related]
6. The human KDR/flk-1 gene contains a functional initiator element that is bound and transactivated by TFII-I.
Wu Y; Patterson C
J Biol Chem; 1999 Jan; 274(5):3207-14. PubMed ID: 9915861
[TBL] [Abstract][Full Text] [Related]
7. Accurate positioning of RNA polymerase II on a natural TATA-less promoter is independent of TATA-binding-protein-associated factors and initiator-binding proteins.
Weis L; Reinberg D
Mol Cell Biol; 1997 Jun; 17(6):2973-84. PubMed ID: 9154795
[TBL] [Abstract][Full Text] [Related]
8. Human Müllerian-inhibiting substance promoter contains a functional TFII-I-binding initiator.
Morikawa N; Clarke TR; Novina CD; Watanabe K; Haqq C; Weiss M; Roy AL; Donahoe PK
Biol Reprod; 2000 Oct; 63(4):1075-83. PubMed ID: 10993829
[TBL] [Abstract][Full Text] [Related]
9. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
Banders UT; Coussens PM
Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
[TBL] [Abstract][Full Text] [Related]
10. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
Furlong EE; Rein T; Martin F
Mol Cell Biol; 1996 Oct; 16(10):5933-45. PubMed ID: 8816507
[TBL] [Abstract][Full Text] [Related]
11. YY1 is a positive regulator of transcription of the Col1a1 gene.
Riquet FB; Tan L; Choy BK; Osaki M; Karsenty G; Osborne TF; Auron PE; Goldring MB
J Biol Chem; 2001 Oct; 276(42):38665-72. PubMed ID: 11514536
[TBL] [Abstract][Full Text] [Related]
12. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
Lieu PT; Wagner EK
Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
[TBL] [Abstract][Full Text] [Related]
13. Chicken YB-2, a Y-box protein, is a potent activator of Rous sarcoma virus long terminal repeat-driven transcription in avian fibroblasts.
Swamynathan SK; Nambiar A; Guntaka RV
J Virol; 1997 Apr; 71(4):2873-80. PubMed ID: 9060644
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.
Greuel BT; Sealy L; Majors JE
Virology; 1990 Jul; 177(1):33-43. PubMed ID: 2162108
[TBL] [Abstract][Full Text] [Related]
15. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
Boulden A; Sealy L
Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
[TBL] [Abstract][Full Text] [Related]
16. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
Houtz EK; Conklin KF
J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553
[TBL] [Abstract][Full Text] [Related]
17. Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter.
Ye J; Young HA; Ortaldo JR; Ghosh P
Nucleic Acids Res; 1994 Dec; 22(25):5672-8. PubMed ID: 7838721
[TBL] [Abstract][Full Text] [Related]
18. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus.
Eichbaum QG; Iyer R; Raveh DP; Mathieu C; Ezekowitz RA
J Exp Med; 1994 Jun; 179(6):1985-96. PubMed ID: 8195721
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the transcription start site core region and transcription factor YY1 determine ascorbate transporter SVCT2 exon 1a promoter activity.
Qiao H; May JM
PLoS One; 2012; 7(4):e35746. PubMed ID: 22532872
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor YY1 is a vaccinia virus late promoter activator.
Broyles SS; Liu X; Zhu M; Kremer M
J Biol Chem; 1999 Dec; 274(50):35662-7. PubMed ID: 10585445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
